Citation

Jain M, Wernick R. Ann. Intern Med. 2014; 161(2): JC3.

Copyright

(Copyright © 2014, American College of Physicians)

DOI

10.7326/0003-4819-161-2-201407150-02003

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

Humans; human; suicide; systematic review; primary prevention; hospitalization; kidney disease; rhabdomyolysis; priority journal; note; heart infarction; hydroxymethylglutaryl coenzyme A reductase inhibitor; treatment withdrawal; drug safety; placebo; cerebrovascular accident; secondary prevention; drug efficacy; meta analysis; cost; myalgia; creatine kinase; myopathy; neoplasm; Cochrane Library; Hydroxymethylglutaryl-CoA Reductase Inhibitors; liver function test; randomized controlled trial (topic); Medline; adverse drug reaction; cardiovascular mortality